The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A machine learning model for predicting recurrence and survival in stage I-III colorectal cancer.
 
Mariam Manukyan
No Relationships to Disclose
 
Tigran Gevorkyan
No Relationships to Disclose
 
Aydar Akhmetzyanov
No Relationships to Disclose
 
Maxim Kirsanov
No Relationships to Disclose
 
Rukiyat Abdulaeva
No Relationships to Disclose
 
Yana Belenkaya
No Relationships to Disclose
 
Maryana Mandrina
No Relationships to Disclose
 
Valeria Pavlova
No Relationships to Disclose
 
Alexey Tryakin
Stock and Other Ownership Interests - Amgen; Bayer; Lilly; Merck; Merck Serono
Consulting or Advisory Role - Amgen; AstraZeneca; BioCad; Bristol-Myers Squibb; Eisai; Lilly; Merck Sharp & Dohme; Petrovax; Roche/Genentech
Speakers' Bureau - Amgen; AstraZeneca/Daiichi Sankyo; Bayer; Bayer Health; BioCad; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Research Funding - Biocad (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BioCad; Merck Serono; Novartis; Petrovax; Sanofi; Veropharm
 
Sergey Gordeev
No Relationships to Disclose